Knarik Arakelyan

Europe has never had more powerful tools against cancer. But progress means little if patients cannot reach them in time. Cancer has never moved at the speed of bureaucracy. Today, science can identify molecular alterations that were once invisible. Biomarker…

After more than four decades under the leadership of Alberto Costa, the European School of Oncology enters a new chapter with Rossella Blasi as CEO. The transition brings together the legacy of Umberto Veronesi’s founding vision and the challenge of…

Science is moving at extraordinary speed. We can identify mutations once invisible, develop drugs that destroy proteins previously considered untouchable, and transform diagnoses that once offered little hope. Yet a patient can still wait too long for treatment. A brilliant…

When Brett Wilson finished cancer treatment at the age of 12, a hospital nurse walked outside with her and her mother and offered three words of advice: “Go be normal.” Wilson looked at her mother. “What does that mean? Go…

The history of pediatric oncology is one of extraordinary progress. Children who once had little chance of surviving cancer are now growing into adulthood, building careers, raising families and imagining futures that previous generations could not. But progress has also…

10 Years of PICI: From Discovery to Impact Ten years ago, the Parker Institute for Cancer Immunotherapy (PICI) was created around a bold premise: that progress in cancer research could be accelerated by changing not only what science pursued, but…

After surviving cervical cancer at 25, Tamika Felder transformed personal tragedy into a global movement. In this CancerWorld interview, she reflects on fear, stigma, infertility, survivorship, advocacy, and why the world already has everything it needs to eliminate one of…

For sixteen years, cancer became something we spoke about in the past tense. My wife, Lynn, had survived a rare smooth-muscle cancer (leiomyosarcoma) after two operations in 2009. Year after year the scans came back clear. Gradually, we stopped living…

The European cancer community has lost one of its most influential voices for breast cancer advocacy. Dr. Mary Buchanan—physician, advocate, and one of the founding figures of Europa Donna – The European Breast Cancer Coalition—passed away on 18 June 2026.…

When Martha Raymond, the Founder and CEO of the GI Cancers Alliance and the Raymond Foundation,  was seven years old, she lost her father to colon cancer. Years later, her mother's illness would change the course of her own life.…